SA
Sign upLog In
ADMA

ADMA Cost of Revenue

$180.81MTTM · USD

Period ending:

QuarterlyTTMAnnualChart Studio →
ADMA FY Cost of RevenueUSD
ADMA FY Cost of Revenue2007-06-30: $0.002008-06-30: $0.002009-06-30: $0.002010-06-30: $0.002011-06-30: $0.002012-12-31: $669.06K2013-12-31: $2.02M2014-12-31: $3.74M2015-12-31: $4.31M2016-12-31: $6.36M2017-12-31: $29.16M2018-12-31: $42.19M2019-12-31: $39.50M2020-12-31: $61.29M2021-12-31: $79.77M2022-12-31: $118.82M2023-12-31: $169.27M2024-12-31: $206.90M2025-12-31: $217.41M$217.41M$0.00
2007-06-302025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ADMA cost of revenue history

Direct costs attributable to producing goods sold. The available annual fiscal periods series contains 19 observations from Jun 30, 2007 to Dec 31, 2025.

Adma Biologics Inc Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
217,408,000
206,901,000
169,273,000
118,815,000
79,770,000
61,291,426
39,504,238
42,194,635
29,164,321
6,360,761
4,311,461
3,742,367
2,023,441
669,056
0
0
0
0
0

Compare cost of revenue

All ADMA financial metrics · ADMA stock overview · How to interpret financial metrics

Explore More

Stock Comparison

Compare equities side by side

52-Week Highs Breakout

Stocks breaking to new annual highs

52-Week Lows Oversold

S&P 500 oversold value screener

Trending Momentum

Relative strength momentum leaders

Earnings Calendar

Upcoming earnings dates & reports

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.